Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $21,267 - $23,620
250 Added 10.23%
2,693 $238,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $16,295 - $18,856
188 Added 8.34%
2,443 $211,000
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $18,337 - $24,509
209 Added 10.22%
2,255 $219,000
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $165,582 - $222,256
2,046 New
2,046 $211,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Fund Management At Engine No. 1 LLC Portfolio

Follow Fund Management At Engine No. 1 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.